KEGG   DRUG: Betibeglogene autotemcel
Entry
D11930                      Drug                                   
Name
Betibeglogene autotemcel (USAN/INN);
Zynteglo (TN)
Product
ZYNTEGLO (bluebird bio)
Remark
ATC code: B06AX02
Product: D11930<US>
Efficacy
Hematologic disease treatment
  Disease
beta-Thalassemia [DS:H00228]
  Type
Cellular therapy product
Comment
Treatment of betathalassemia
Target
CD34 [HSA:947] [KO:K06474]
  Pathway
hsa04514  Cell adhesion molecules
hsa04640  Hematopoietic cell lineage
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 B BLOOD AND BLOOD FORMING ORGANS
  B06 OTHER HEMATOLOGICAL AGENTS
   B06A OTHER HEMATOLOGICAL AGENTS
    B06AX Other hematological agents
     B06AX02 Betibeglogene autotemcel
      D11930  Betibeglogene autotemcel (USAN/INN) <US>
Target-based classification of drugs [BR:br08310]
 Cell surface molecules and ligands
  Other cell surface molecules
   CD molecules
    CD34
     D11930  Betibeglogene autotemcel (USAN/INN) <US>
New drug approvals in the USA [br08319.html]
 Cellular and gene therapy products
  D11930
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D11930
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system